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Abstract
Influenza A viruses contain two S-acylated proteins, the ion channel M2 and the gly-
coprotein hemagglutinin (HA). Acylation of the latter is essential for virus replication.
Here we analysed the expression of each of the 23 members of the family of ZDHHC
acyltransferases in human airway cells, the site of virus replication. RT-PCR revealed
that every ZDHHC acyltransferase (except ZDHHC19) is expressed in A549 and Calu
cells. Interestingly, expression of one ZDHHC, ZDHHC22, is upregulated in virus-
infected cells; this effect is more pronounced after infection with an avian compared
to a human virus strain. The viral protein NS1 triggers ZDHHC22 expression in trans-
fected cells, whereas recombinant viruses lacking a functional NS1 gene did not
cause ZDHHC22 upregulation. CRISPR/Cas9 technology was then used to knock-
out the ZDHHC22 gene in A549 cells. However, acylation of M2 and HA was not
reduced, as analysed for intracellular HA and M2 and the stoichiometry of S-acylation
of HA incorporated into virus particles did not change according to MALDI-TOF mass
spectrometry analysis. Comparative mass spectrometry of palmitoylated proteins in
wt and ΔZDHHC22 cells identified 25 potential substrates of ZDHHC22 which
might be involved in virus replication.
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1 | INTRODUCTION
Hemagglutinin of Influenza A virus is a type I transmembrane glyco-
protein with a large ectodomain, a single transmembrane region and a
short cytoplasmic tail (Gamblin et al., 2020). HA is acylated with dif-
ferent fatty acids at three highly conserved cysteines. Two are located
in the cytoplasmic tail and are exclusively acylated with palmitate; the
third is located at the end of the transmembrane region and is acyl-
ated with stearic acid (Brett et al., 2014; Kordyukova, Serebryakova,
Baratova, & Veit, 2009). These hydrophobic modifications are crucial
for virus replication, as demonstrated by the observation that virus
mutants lacking more than one acylation site showed either a signifi-
cant decrease in virus growth or could not be rescued at all by reverse
genetics (Chen, Takeda, & Lamb, 2005; Siche et al., 2015; Wagner,
Herwig, Azzouz, & Klenk, 2005; Zurcher, Luo, & Palese, 1994).
Influenza A virus contains another palmitoylated protein, the pro-
ton channel M2, which is modified by fatty acids at a cysteine located
in an amphiphilic helix that has been proposed to mediate the budding
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of virus particles (Rossman, Jing, Leser, & Lamb, 2010; Sugrue, Bel-
she, & Hay, 1990; Veit, Klenk, Kendal, & Rott, 1991). Virus mutants
with deleted acylation sites revealed no growth defect in cell culture,
even if it was exchanged simultaneously with a cholesterol-binding
site (Castrucci et al., 1997; Grantham et al., 2009; Thaa et al., 2012).
However, acylation of HA and M2 work synergistically with each
other, and recombinant viruses with non-acylated M2 are modestly
attenuated in mice, indicating that acylation has a beneficial effect for
virus replication in vivo (Grantham et al., 2009; Veit & Siche, 2015).
Palmitoylation is catalysed by a family of protein acyltransferases
known as the ZDHHC family, a group of polytopic membrane proteins
containing an Asp-His-His-Cys (DHHC) motif as the catalytic center in
one of their cytoplasmic domains. The DHHC-motif is embedded within
a cysteine-rich domain (CRD) that is a variant of the zinc finger motif.
Twenty-three ZDHHC proteins are expressed in humans, and each show
distinct, but overlapping, substrate specificities (Chamberlain &
Shipston, 2015; Zaballa & van der Goot, 2018). Most ZDHHC proteins
are abundant in many tissues, but some are expressed in only a few cell
types. The majority of ZDHHC proteins localise to Golgi membranes,
while smaller numbers are found in the endoplasmic reticulum (ER) or
are targeted to the plasma membrane (Ernst et al., 2018; Ohno, Kihara,
Sano, & Igarashi, 2006). Besides the cysteine-rich domain, little sequence
conservation occurs between proteins. It thus might be feasible to
develop small molecules that specifically target only one or a few
ZDHHCs, and this development might be facilitated by the recently
resolved 3D structures of two ZDHHCs (Rana et al., 2018). Small mole-
cules targeting certain ZDHHCs might be promising antiviral drugs, if
they inhibit a modification essential for virus replication while not per-
turbing acylation of most cellular proteins (Gadalla & Veit, 2019).
We have recently shown that acylation of M2 and HA was greatly
reduced if the genes encoding ZDHHC2, 8, 15 and 20 were inactivated
by CRISPR/Cas9 (Gadalla, Abrami, van der Goot, & Veit, 2020). This
was demonstrated in HAP1 cells, a human leukaemia cell line having
only a single copy of almost every chromosome and hence ideally
suited for the CRISPR/Cas9 technology. Following this, we were inter-
ested to determine which ZDHHCs are present in human lung cells, the
original site of Influenza virus replication, and whether tissue-specific
expression patterns of ZDHHCs change upon virus infection.
The viral NS1 protein is one of the key virulence factors of the
Influenza A virus. It inhibits various cellular processes, mostly in order
to impair the innate immune response of the host (Hrincius et al., 2014;
Klemm, Boergeling, Ludwig, & Ehrhardt, 2017; Krug, 2015; Schneider &
Wolff, 2009). NS1's antagonising effects range from inhibiting intracel-
lular virus sensors and signalling pathways to impairing mRNA
processing, export, and translation. In addition, it has been recently
shown that NS1 produces dynamic changes in the three-dimensional
organisation of the host genome, where it induces read through tran-
scription of hundreds of kilobases at the end of highly transcribed
genes via inhibition of transcription termination. The activity of NS1 is
a consequence of inhibiting the poly(A) sensing (PAS) subunit of the
cleavage and polyadenylation specificity factor CPSF30. Whether this
massive upregulation of cellular genes has an effect on influenza virus
replication is not known (Heinz et al., 2018).
We show here that NS1 induces the upregulation of one pal-
mitoyl acyltransferase, ZDHHC22, in virus-infected human lung cell
lines. While ZDHHC22 is apparently not required for acylation of HA
and M2, we nevertheless were able to identify 25 putative cellular
substrates of this enzyme by quantitative mass spectrometry.
2 | RESULTS
2.1 | All members of the ZDHHC family (except
ZDHHC19) are expressed in human lung cells
We first analysed the expression pattern of members of the ZDHHC
palmitoyl acyltransferase family in the human lung cell line A 549. This
is of interest as many viral pathogens that infect via the respiratory
route contain at least one acylated membrane protein, yet the responsi-
ble ZDHHCs have only been identified for HA of the Influenza A virus
(Gadalla et al., 2020). We designed primer pairs for RT-PCR in such a
manner that each primer binds to a different exon to ensure that ampli-
fied gene fragments are derived from the mRNA, not from the genomic
DNA (Table S1). Agarose electrophoresis of the resulting products from
RNA isolated from uninfected cells showed a band of the expected size
for most ZDHHCs, except ZDHHC15 and 19 (Figure S1). Note, how-
ever, that we later detected ZDHHC15 (but not ZDHHC19) by qPCR.
To evaluate whether the same ZDHHC expression pattern exists in
native human lung cells, we consulted the Human Protein Atlas
(https://www.proteinatlas.org/), a database that maps global expression
patterns of proteins in human cells, tissues and organs using integration
of various “Omics” technologies. From the ZDHHCs quantified by mass
spectrometry, only ZDHHC8 was not detected in various tissues of the
respiratory tract (nasopharynx, bronchus and lung). However, expres-
sion of ZDHHC8 was detected by RNAseq at fairly high levels in bulk
lung tissue. The only ZDHHCs not detected by RNAseq are ZDHHC22
and ZDHHC19, the latter of which being consistent with our RT-PCR
and qPCR-based observations. Note also that substantial differences
exist in the ZDHHC expression levels between epithelial cells in the
upper respiratory tract (nasopharynx and bronchus) versus
pneumocytes and macrophages in the lung (Table S2).
Since infected cells express high levels of HA, which must be fully
acylated to function properly, and since most ZDHHCs are present
only at a low copy number (Zaballa & van der Goot, 2018), we asked
whether the influenza virus might induce overexpression of certain
ZDHHCs upon infection. We infected A549 cells with the “human”
virus WSN (H1N1) at an MOI of 1. RNA was extracted 5 hr post infec-
tion from both infected and uninfected cells, reverse transcribed to
cDNA, and relative expression of ZDHHCs was analysed by qPCR
(primers are listed in Table S3). Calculation of the mRNA changes
upon infection revealed that one ZDHHC gene, ZDHHC22, was
upregulated fivefold (Figure 1a). Upregulation of ZDHHC22 was even
higher (25-fold) if A549 cells were infected with a variant of avian
fowl plaque virus (FPV M1, H7N1 [Wagner et al., 2013]) (Figure 1b).
We performed the same experiment with another human lung cell line
(Calu-3 cells) which also revealed significant upregulation of
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ZDHHC22. The calculated fold changes were even higher (15-fold) if
the Calu-3 cells were infected, with WSN virus and 30-fold if infected
with FPV M1 (Figure 1c,d). The exact values of the fold changes for
each ZDHHC (mean of three experiments) are depicted in Table S4).
Note also that the qPCR analysis further confirmed that Calu-3 cells,
like A549 cells, also express every ZDHHC gene except ZDHHC19.
We next analysed expression of ZDHHC22 at different times
points after infection with FPV M1. In A549 cells, upregulation of
ZDHHC22 was first detected at 3 hr p. i., was elevated several fold at
5 h p. i. and increased further at 7, 9 and 12 hr p. i. In Calu-3 cells
upregulation was first evident at 5 hr p. i., but is much more promi-
nent at 9 and 12 hr post infection (Figure S2). This is consistent with
the observation that the expression of NS1 increases during the
course of virus replication (Kummer et al., 2014).
2.2 | Influenza virus protein NS1 induces
upregulation of ZDHHC22 expression
NS1 is the key protein of the influenza virus that modulates the host's
innate immune response to infection. In addition, NS1 causes read-
through transcription at the end of highly transcribed cellular genes,
leading to the expression of several hundred additional genes. The
mechanism is likely to involve inhibition of polyadenylation signal
(PAS)-dependent transcription termination as a consequence of the
binding of NS1 to the polyadenylation-sensing subunit of CPSF30
(Heinz et al., 2018). Thus, we hypothesized that NS1 might be also
responsible for the induction of ZDHHC22 upregulation. To test this,
we transfected A549 cells with NS1-encoding plasmids from three
different influenza strains: from WSN and FPV, but also from the
human strain PR8 (Puerto Rico/8/1934, H1N1), which is closely
related to WSN but does not bind to CPSF30. qPCR analysis revealed
that all NS1 proteins induced expression of ZDHHC22, but to differ-
ent extents (Figure 2a). FPV-NS1 had the strongest effect; it increased
expression of ZDHHC22 by about sixfold, while NS1 of WSN and
PR8 caused a threefold upregulation. This corresponds to the effect
seen in virus-infected cells, where avian FPV M1 induced a higher
upregulation compared to WSN. Western-blotting of cell lysates rev-
ealed that NS1 proteins from the human viruses WSN and PR8 are
expressed at similar levels, However, the antibody does not recognise
NS1 from FPV M1 and thus we cannot exclude completely that the
stronger effect of avian NS1 is due to a higher expression level.
We next validated the specificity of NS1-induced upregulation of
ZDHHC22 using an available PR8 virus mutant deficient in NS1
expression. Whereas PR8 wt infection increased expression of
ZDHHC22 fourfold, no change in the expression level of ZDHHC22
F IGURE 1 ZDHHC22 is upregulated by IAV infection in A549 and Calu-3 cells. A549 cells (a, b) or Calu-3 cells (c, d) were mock infected or
infected with WSN (a,c) or with the M1 mutant of FPV (b, d) with an MOI of 1 for 5 hr. Total RNA was isolated, reverse transcribed to cDNA and
qPCR was performed to determine the expression of different ZDHHCs. To calculate the fold change of expression of each ZDHHC gene
(infected compared to non-infected control), Ct-values of the GAPDH housekeeping gene were subtracted from the Ct-value of each ZDHHC
gene and then the relative expression levels displayed as fold change were calculated using the Livak method (2−ΔΔCT) (Livak & Schmittgen,
2001). Shown is the mean including standard deviation from three independent experiments. Note that expression of ZDHHC15, but not
ZDHHC19, was detected by qPCR. Two-way ANOVA followed by Bonferroni's multiple comparison test was applied on delta CT values for
statistical analysis. The asterisks indicate statistically significant differences (***p < .005, ***p < .0001) between mock and virus infected cells
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was detected in cells infected with ΔNS1 mutant virus (Figure 2b).
We also analysed a more recent human strain, A/Panama/2007/99,
which belongs to the H3N2 subtype. This virus also upregulates
expression of ZDHHC22 around 2.5-fold, but the corresponding
ΔNS1 mutant virus had no effect. Western-blotting showed that NS1
of PR8 and Panama are expressed at similar levels. Together, these
results clearly show that NS1 is responsible for the upregulation of
ZDHHC22 and that an NS1 protein from an avian virus had a stronger
effect than NS1 proteins from human viruses.
2.3 | No effect of ZDHHC22 knockout on
palmitoylation of HA and M2 inside cells
Since Influenza virus induced the expression of ZDHHC22 in lung
cells, we hypothesized that this enzyme might play a critical role in
acylation of HA and/or M2. To test this hypothesis, we aimed to
generate a A549 ZDHHC22 knockout cell line using CRISPR/Cas9
technology (Figure 3a). Two guide RNAs (gRNAs) (Table S5) were
designed targeting exon-2 of the ZDHHC22 gene, which encodes the
DHHC domain responsible for the catalytic activity of the enzyme.
The two gRNAs were cloned into the pRP-418 vector which also
encodes the Cas9 nuclease. After transfection, selection and isolation
of single cell clones, we screened for the desired mutation. Due to
lack of validated antibodies for most members of the ZDHHC family
(including ZDHHC22), we relied on genetic approaches on both the
DNA and RNA levels to validate the knockout. PCR measurements of
genomic DNA revealed a gene fragment of 700 bp in wild-type
(WT) cells, whereas the corresponding fragment is only 400 bp in a
knockout (KO) cell line indicating that it contains the anticipated
248-bp deletion on both chromosomes (Figure 3b). This was con-
firmed by sequencing of a chromosomal PCR product of the
ZDHHC22 gene. Whereas wild-type cells exhibit the expected DNA
sequence, the A549 ZDHHC22 knockout cell line contains a deletion
F IGURE 2 Influenza virus NS1 induces upregulation of ZDHHC22. (a) Plasmids encoding NS1 of three different influenza virus strains (WSN,
FPV and PR8) or the empty pCAGGS vector were used for transfection of A549 cells. Twenty-four hours post-transfection total RNA was
isolated and the fold-change of expression of ZDHHC22 gene was determined as described in Figure 1. Expression data are normalised to empty
vector control and results are shown as the mean of three transfections including standard deviation. The asterisks indicate statistically significant
differences (*p < .05, **p < .001, ***p < .0005) between mock and transfected/infected cells. One-way ANOVA followed by Tukey's multiple
comparison test was applied for statistical analysis. ns, not significant. The lower part shows a western-blot of a cellular lysate prepared at 24 hr
post transfection using a monoclonal antibody against the NS1 protein. (b) A549 cells were infected with an MOI of 1 with PR8 or Panama virus,
either wild-type or mutant viruses with deletions in the NS1 gene. Five hours post infection total RNA was isolated and the fold-change of
expression of ZDHHC22 gene was determined as described in Figure 1. Expression data are normalised to non-infected cells and results are
shown as the mean of three infections including standard deviation. The mean ± standard deviation is shown. The asterisks indicate statistically
significant differences (*p < .05, **p < .001, ***p < .0005) between mock and transfected/infected cells. One-way ANOVA followed by Tukey's
multiple comparison test was applied for statistical analysis. ns, not significant. The lower part shows a western-blot of a cellular lysate prepared
at 5 hr post transfection using a monoclonal antibody against the NS1 protein
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of 248 nucleotides between base positions 116 and 366 (Figure 3c).
Since this deletion results in a frameshift in exon-2 it is unlikely that
the knockout cells are able to synthesise a functional ZDHHC protein,
even if the mRNAs are translated.
Using the ZDHHC22 knock-out cells we first investigated by
qPCR whether expression of the other ZDHHC genes was altered rel-
ative to wild-type A549 cells. The results revealed that the expression
levels of seven ZDHHC genes (1, 7, 8, 9, 13, 20 and 24) remained
essentially unchanged. However, many ZDHHC genes were down-
regulated; ZDHHCs 2, 3,4, 5, 6, 16, 21 and 23 between 20% and
30% and three more clearly, ZDHHCs 11, 14, and 15 by up to 50%.
Only two ZDHHC genes were slightly upregulated, ZDHHC12 by
25% and ZDHHC18 by 50% (Figure S3). This suggests that
ZDHHCs apparently form a complex network; at least the ZDHHC22
gene apparently influences the expression of many other ZDHHC
genes.
Having successfully inactivated the ZDHHC22 gene, we examined
palmitoylation of influenza HA using acyl-RAC (resin-assisted capture),
a technique that allows the capture of S-acylated proteins on
thioreactive sepharose beads (Werno & Chamberlain, 2015). Wt and
knock-out cells were infected with WSN virus and lysed, and a 5% ali-
quot was used to compare the expression levels of HA. One aliquot of
the remaining lysate was treated with hydroxylamine to cleave
thioester-linked fatty acids, while the other aliquot was treated with
F IGURE 3 Knockout of ZDHHC22 in A549 cells using CRISPR/Cas9. (a) Upper part: Scheme of the human ZDHHC22 protein showing the
DHHC motif located between the second and third transmembrane domains (TM2 and TM3). Lower part: Scheme of a region of the gene
encoding ZDHHC22. The sequence of exon 2 is shown below. The binding sites of the guide-RNAs are highlighted in blue and the sequence
encoding the DHHC motif is highlighted in green. (b) PCR products from genomic DNA (gDNA) isolated from wild type (WT) and knockout cell
lines showing biallelic deletion of a  250 bp region in exon-2 of ZDHHC22. (c) Sequencing chromatograms of knockout (KO) and wild type
(wt) A549 cells. The binding site of the guide RNA is underlined in the wt sequence. The Cas9 cutting site is indicated by a vertical dotted line.
The deletion of 248 bp generates a frameshift in the coding sequence. Parts of the ZDHHC22 gene encompassing the guide RNA binding site
were amplified from the genomic DNA by PCR using the primers listed in Table S1
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Tris–HCl such that neither cleavage nor bead-binding was expected.
Thiol-reactive resins were then added to both aliquots and precipi-
tated proteins were subjected to Western blotting with HA-reactive
antiserum. Figure 5a shows that HA is expressed to similar levels and
with the same molecular weight in both wt and ZDHHC22 knock-out
cells (Figure 5a, input). Most importantly, acyl-RAC revealed that HA
is still palmitoylated in ZDHHC22 knock-out cells and apparently to
the same extent as in wt cells (Figure 4a, acyl-RAC).
We then investigated whether expression of ZDHHC22 might be
upregulated because it catalyses fatty acid attachment to M2, the sec-
ond palmitoylated protein of Influenza virus. The same blot membrane
was treated with M2 antibodies, but the result also showed that M2
is acylated to the same extent in wt and ZDHHC22 knock-out cells
(Figure 4a).
As FPV increased the expression of ZDHHC22 to a much larger
degree than WSN, we asked whether an effect of this enzyme on
acylation of HA might be more pronounced and thus easier to detect.
This is also interesting since HA of FPV belongs to the phylogenetic
group 2, which might exhibit a different structure in the transmem-
brane region (containing a putative enzyme recognition motif) than
the group 1 HA of WSN. Despite these differences, HA of FPV was
seen to be acylated to the same extent in both wt and ΔZDHHC22
cells (Figure 4b).
Acyl-RAC captures HA synthesised at every time point of infec-
tion, and thus also before expression of ZDHHC22 is induced. There-
fore, we investigated palmitoylation of HA with another method,
metabolically labelling with a clickable palmitic acid analogue
(17-ODYA) from 5 to 11 hr after virus infection. Immunoprecipitated
HA is then coupled to a fluorescent dye (TAMRA-Azide) by click
chemistry (Martin, 2013). Visualisation of the fluorescence in an SDS
gel revealed that HA of both WSN and FPV M1 were labelled to the
same extent in wild type and ΔZDHHC22 cells (Figure 4c).
2.4 | MALDI-TOF shows that HA incorporated
into virus particles is fully acylated
It is possible that ZDHHC22 might be specific for stearate or palmi-
tate and in its absence the vacant cysteine is filled by another
acyltransferase having another lipid preference. This shift would not
F IGURE 4 Effect of ZDHHC22
knock-out on palmitoylation of influenza
virus HA and M2. (a) Wildtype and
ΔZDHHC22 A549 cells were infected
with a MOI of 1 with WSN virus or were
kept uninfected (mock). After 24 hr, cells
were lysed and subjected to acyl-RAC and
Western blotting. Left, Input: Western
blot of 5% of the lysate to check
expression levels of HA and M2. Right,
acyl-RAC. NH2OH: samples treated (+) or
not treated (−) with hydroxylamine to
cleave thioester-bound fatty acids. Both
HA and M2 antibodies were used for the
same blot membrane. (b) Wildtype and
ΔZDHHC22 A549 cells were infected
with a MOI of 1 with FPV M1 influenza
virus or kept uninfected (mock). After
24 hr, cells were lysed and subjected to
acyl-RAC and Western blotting (IB) with
antiserum against the HA2 subunit.
(c) Wildtype and ΔZDHHC22 A549 cells
were infected with an MOI of 1 with
WSN or FPV M1 Influenza virus or kept
uninfected (mock), as indicated. Cells
were labelled 5 hr post infection with the
fatty acid analogue 17-ODYA for 6 hr.
Viral HA was immunoprecipitated from
cellular extracts, 17-ODYA was coupled
via click-chemistry to a fluorophore, and
the samples were subjected to SDS-
PAGE. Gels with fluorescently labelled
protein was detected by a 9400 Typhoon
scanner
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F IGURE 5 MALDI-TOF MS analysis of HA from viruses grown in wild type or ΔZDHHC22 A549 cells. (a, b, d, e) MALDI-TOF MS analysis of HA
peptides obtained from FPV M1 (a, b) and WSN (d, e) grown in wt (a, d) or ΔZDHHC22 (b, e) A549 cells. Mass spectra obtained in linear mode are
depicted. Indicated are the m/z values of the peaks, the first and the last amino acid residues of the corresponding peptides, mono-
carbamidomethylation (cbm; + 57 m/z) of the peptides containing a free cysteine in the middle of TMR and the number and type of HA-bound fatty
acids. The stearate amount (+ standard deviation) was calculated for the FPV HA [513–563] and WSN HA [514–565] peptides. Every mass spectrum
was obtained as the sum of at least 200 laser shots. Two (WSN wt) or one virus preparation were analysed and at least four mass spectra for every
virus sample were recorded and the stearate content was calculated. (c, f) Amino acid sequences of the C-terminal regions of FPV M1 HA (c) and WSN
HA (f) indicating the sites of cleavage by trypsin and cysteine modifications. Cysteines that may be potential acylation sites are enlarged and the TMR
is underlined. Stear: stearate, Pal: palmitate. The modification of free cysteine located in the middle of FPV HA TMR by a carbamidomethyl group was
detected after the reaction with iodoacetamide, as described in Materials and Methods. No mono-carbamidomethylated peptides were detected for
WSN HA lacking a free cysteine in the middle of TMR. Importantly, neither double- nor triple-carbamidomethylated peptides were detected for any
HA, meaning that no potential acylation sites are free in any HA peptides, but are rather modified with fatty acids
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be obvious by the methods thus far described, as neither acyl-RAC
nor metabolic labeling can discriminate between the palmitate and
stearate attachments. Thus, we used MALDI-TOF mass spectrometry
to more quantitatively analyse the fatty acid patterns of HA in virus
particles (WSN and FPV M1) prepared from WT and ΔZDHHC22
knockout cell lines (Brett et al., 2014). Pelleted virus particles were
treated with iodoacetamide to prevent cysteine-mediated aggregation
of proteins that would also reveal free cysteines and thus non- and
under-acylated peptides. After separation by non-reducing SDS-
PAGE, protein bands were electro-blotted onto membranes and vis-
ualised by Ponceau S staining. The band corresponding to HA was cut
from the membrane, digested with trypsin, and the resulting peptides
were eluted and analysed by MALDI-TOF MS.
HA from FPV M1 grown in wt A549 cells is cut after arginine
512, located 15 amino acids upstream from the TMR, resulting in a
peptide that matches to the complete membrane-anchoring plus
linker region spanning amino acids 514–563 (Figure 5a,c). The peptide
is present as one main peak representing a peptide containing two
palmitates and one stearate. In addition, two minor peaks we
observed, corresponding to a peptide containing one palmitate and
two stearates and a triple palmitoylated peptide. The calculated stea-
rate content is 39.6% (mean of two virus preparations), and thus 10%
higher than previously determined for HA of the same virus grown in
embryonated eggs. The same pattern of peaks was obtained if FPV
M1 was grown in the ΔZDHHC22 cell and the same percentage of
stearate was calculated (Figure 5b). Most notably, no peptides with a
lower m/z value representing non- or under-acylated peptides
(possessing carbamidomethylated instead of S-acylated cysteines)
were detected, providing evidence that knocking out ZDHHC22 has
no effect on the stoichiometry of S-acylation of HA of FPV meaning
that all potential S-acylation sites are occupied.
We then performed the same analysis with HA of WSN virus.
Trypsin cuts HA of WSN grown in wt A549 cells mainly after arginine
513, but also after lysine 515 to a lesser extent. Each of the resulting
peptides is observed as two main peaks representing a triple
palmitoylated peptide and a peptide containing two palmitates and
one stearate (Figure 5d,f). The calculated stearate content is 19% and
thus slightly lower compared to WSN grown in MDCK cells (23%), but
higher if the same virus was grown in embryonated eggs (8%) (Brett
et al., 2014). If WSN was grown in ΔZDHHC22 cells the same peptide
pattern was observed, only an increase in the stearate content to 24%
was calculated. Most importantly, no peaks representing non- or
under-acylated peptides were detected (Figure 5e), demonstrating
that HA in virus particles is fully acylated.
2.5 | Potential substrates of ZDHHC22 palmitoyl
acyltransferase identified by LC–MS/MS
Knockout of ZDHHC22 did not show any effect on the acylation pat-
terns of either intracellular or virus-incorporated HA. Thus, we
hypothesized that NS1 might induce upregulation of ZDHHC22 to
acylate cellular proteins. We used acyl-RAC for enrichment of
palmitoylated proteins coupled with 16O/18O-labeling for quantifica-
tion of the palmitoylome of ΔZDHHC22 cells relative to A549 wild
type cells (Morrison et al., 2015). WT and ΔZDHHC22 cells were
homogenised and cellular lysates were subjected to the acyl-RAC pro-
cedure in the presence of NH2OH or in its absence (control), followed
by binding to thiopropyl sepharose beads. After elution, enriched and
control samples were run in parallel lanes of an SDS-PAGE gel. These
lanes were horizontally cut into equal-sized bands which were sub-
jected to in-gel trypsin proteolysis in the presence of H2
18O (“heavy”
water) and H2
16O (“light” water) for NH2OH treated and untreated
samples, respectively. This leads to the enzymatic incorporation of
one (via hydrolysis of the peptide bond by trypsin) or two (via hydroly-
sis of the acyl-enzyme complex) 18O isotopes at the C-terminus of
peptides from the HA-treated sample. After digestion, samples were
mixed and measured by LC–MS/MS; evaluating the isotopic heavy/
light intensity ratio gives rise to an enriched pool representing the
population of palmitoylated proteins in the cell. Comparing the
palmitome of wt with ΔZDHHC22 A549 cells identified 25 proteins in
both of the two biological replicates as possible substrates of
ZDHHC22 (Table S6), described in more detail below. Quantitative
data from this experiment and details about identified proteins, such
as their accession numbers and predictions from the SwissPalm data-
base are presented in the Appendix S1.
One of the substrates we identified in this screen is the isoform
1 of plakophilin-2 (PKP-2), which is of interest since it has been
described to be palmitoylated and to affect replication of Influenza A
virus (Roberts et al., 2014; Wang et al., 2017). The ZDHHCs which
acylates PKP-2 has not been identified and it is also not known
whether palmitoylation affects the antiviral activity of the protein.
We, therefore, aimed to analyse palmitoylation of PKP-2 in
ΔZDHHC22 cell. When we performed western blots with total cellu-
lar lysates, expression of PKP-2 is barely detectable in knock out cells,
although the protein is abundantly expressed both in uninfected and
virus-infected wt A549 cells (Figure S4). Furthermore, morphological
changes occur in A549 cells during selection of cell clones having an
inactivated ZDHHC22 gene. Wt A549 cells are round and are grown
to high density 5 days after seeding, whereas ΔZDHHC22 cells
remain spindle-shaped and no extensive cell–cell contacts are obvious
by light microscopy. Although we could not analyse palmitoylation of
PKP-2 in ΔZDHHC22 cells due to its very low expression level, the
result is consistent with the function of palmitoylation of PKP-2,
which is important for desmosome assembly and hence cell–cell adhe-
sion (Roberts et al., 2014).
2.6 | Growth of influenza virus is not diminished in
ΔZDHHC22 cells
Finally, we investigated whether abolishment of ZDHHC22 expres-
sion affected virus production. Both wild-type and ΔZDHHC22 cells
were infected with FPV M1 or WSN at a low MOI (0.01), superna-
tants were collected at various time points, and virus titers were
determined by plaque assays in MDCK-II cells. Virus titers were
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almost identical, with a slight increase observed at early time points in
ΔZDHHC22 cells, which is statistically significant for FPV at 12 hr
post infection (Figure 6a,b). However, infection of cells with FPV
M1 at a high MOI of 1 did not reveal a difference (Figure 6c). Thus,
we conclude that the NS1-induced upregulation of ZDHHC22 does
not affect replication of two Influenza A viruses in cell culture.
3 | DISCUSSION
In this study, we first analysed the expression pattern of members of
the ZDHHC palmitoyl acyltransferase family in human lung cells. This
is of interest since many viral pathogens that infect via the respiratory
route contain at least one acylated membrane protein, but the respon-
sible ZDHHCs have only yet been identified for HA of Influenza A
virus. RT-PCR experiments show that every ZDHHC family member,
with the exception of ZDHHC19, is expressed in uninfected A549
and Calu cell lines (Figure S1). This is largely consistent with data in
the Human Protein Atlas, which revealed that every ZDHHC, except
ZDHHC19 and ZDHHC22, has been detected in native human lung
cells (Table S2). After infection with Influenza A virus we observed sig-
nificant upregulation of ZDHHC22 expression in both cell lines, up to
30-fold if an avian strain was used for infection (Figure 1).
Since we assumed that ZDHHC22 might at least contribute to
acylation of influenza virus proteins, we knocked out the ZDHHC22
gene in A549 cells using CRISPR/Cas9 technology (Figure 3). How-
ever, neither acyl-RAC nor metabolic labeling revealed diminished
acylation of HA and M2 of two Influenza A virus strains in
ΔZDHHC22 cells (Figure 4). Mass spectrometry showed that these
cells produced virus particles having a stoichiometrically acylated HA
spike (Figure 5). Only a small increase in the amount of stearate
(C18:0) relative to palmitate (more obvious in the case of WSN HA)
was detected for virus collected from ΔZDHHC22 knockout cell line
compared to wt A549 cells.
F IGURE 6 Growth curve of influenza viruses in wildtype and ΔZDHHC22 knockout cells. WT and ΔZDHHC22 A549 cells were infected with
FPV M1 (a,c) or WSN (b) with an MOI of 0.01 (a, b), or 1 (c) and incubated at 37C in medium containing 0.25 μg/ml TPCK-Trypsin. Aliquots of
the cell culture supernatants were collected at indicated time points and the virus titers were determined by plaque assays in MDCKII cells. The
data from three independent experiments are shown as mean including standard error. One-way ANOVA followed by Tukey's multiple
comparison test showed that there was no statistically significant difference for any growth curve at any time point
GADALLA ET AL. 9 of 17
3.1 | Putative substrates of ZDHHC22
Using quantitative mass spectrometry, we identified 24 proteins that
are acylated in A549 wt cells but not (or at greatly reduced levels) in
ZDHHC22 knock-out cells, suggesting that these proteins are sub-
strates of ZDHHC22. Besides a short isoform of ZDHHC18 (Morrison
et al., 2015; Morrison et al., 2020), ZDHHC22 is the shortest member
of the ZDHHC family, which is mainly localised in the ER/Golgi. Only
two ZDHHC22 substrates have been identified so far, the large con-
ductance calcium-activated potassium (BK) channel and the
nephroblastoma overexpressed protein. In both cases palmitoylation
is required for proper trafficking of the respective protein (Kim
et al., 2018; Tian, McClafferty, Knaus, Ruth, & Shipston, 2012). Three
of the proteins we identified, the regulatory subunit 16A of the pro-
tein phosphatase 1, the calcium sensor synaptotagmin 1, and the iso-
form 1 of plakophilin-2, were already described to be palmitoylated
(Heindel, Schmidt, & Veit, 2003; Roberts et al., 2014). New substrates
we identified include small GTPases and GTPase-activating proteins,
protein kinases and phosphatases, transcriptional regulators and splic-
ing factors, as well as proteins affecting the cytoskeleton and cell–cell
adhesion (Table S6).
Our screen also identified another palmitoyl-transferase,
ZDHHC13, as putative substrate of ZDHHC22. It is tempting to spec-
ulate that ZDHHC13 and ZDHHC22 are part of a palmitoylation cas-
cade, similar to the one involved in acylation of ER-resident protein
folding factors, where ZDHHC6 catalyses fatty acid transfer to the
protein substrate, but its activity is regulated by ZDHHC16-catalysed
palmitoylation of three cytoplasmic cysteines in ZDHHC6 (Abrami
et al., 2017). Besides the cysteine in the DHHC motif, ZDHHC13 con-
tains another cysteine located adjacent to the first transmembrane
region, which might be the putative palmitoylation site. However,
ZDHHC13 was also shown to regulate mitochondria architecture and
function (Maynard et al., 2008; Shen et al., 2017) and to mediate
palmitoylation-dependent magnesium transport into cells (Goytain,
Hines, & Quamme, 2008). Interestingly, other proteins identified in
our screen also localise to mitochondria (NADH–ubiquinone oxidore-
ductase chain 4) or are involved in magnesium transport (the metal
transporter CNNM2).
The isoform 1 of plakophilin-2 is the only protein we identified
that has been described to affect replication of Influenza A virus. In
the nucleus it competes with the viral polymerase subunit PB2 for
binding to the PB1 subunit. This perturbs assembly of a functional
polymerase complex, thereby limiting polymerase activity and subse-
quent viral replication (Wang et al., 2017). In uninfected cells,
plakophilin-2 binds to the cytoplasmic domain of cadherins, cell adhe-
sion molecules of desmosomes at the plasma membrane, and
palmitoylation at a single cysteine is important for desmosome assem-
bly and hence cell–cell adhesion (Roberts et al., 2014). Whether
palmitoylation affects the interaction of plakophilin-2 with the viral
polymerase subunit has not been investigated. We report that expres-
sion of plakophilin-2 is barely detectable in ZDHHC22 knock-out cells
and that these cells exhibit morphological changes, that is, are not able
to form visible cell–cell contacts (Figure S4). We speculate that in the
absence of ZDHHC22, plakophilin-2 is not palmitoylated, cannot
induce the formation of desmosomes and is hence degraded.
To our knowledge none of the other ZDHHC22 or ZDHHC13
substrates has so far been linked to replication of Influenza virus. In
general, palmitoylation of intrinsically hydrophilic substrates recruits
the protein to certain cellular membranes, such that it can perform its
function at a specific location. Palmitoylation of transmembrane pro-
teins might have various functions, facilitating intracellular trafficking
and recruitment to nanodomains in the membrane, promoting associa-
tion with other proteins, or protecting from other post-translational
modifications, such as ubiquitination thereby preventing degradation
(Zaballa & van der Goot, 2018). Palmitoylation of many cellular pro-
teins is reversible and thus the modification resembles phosphoryla-
tion, which is known to be involved in virus replication and evasion of
the innate immune response (Meineke, Rimmelzwaan, &
Elbahesh, 2019).
3.2 | Amino acids and functionalities in NS1
required for ZDHHC22 upregulation
We have also demonstrated that the viral protein NS1 is responsible
for ZDHHC22 upregulation. It triggers ZDHHC22 expression in trans-
fected cells, whereas recombinant viruses lacking a functional NS1 gene
did not cause ZDHHC22 upregulation. From the NS1 proteins analysed
here, NS1 from the avian FPV has the most pronounced effect on over-
expression of ZDHHC22, both if NS1 was expressed from a plasmid
and from the viral genome. However, since the antibody we used could
not detect avian NS1 in transfected cells we cannot exclude that its
stronger effect is due to a higher expression level and not an intrinsic
property of the protein. NS1 from the human H1N1 viruses WSN and
PR8, and also from the more recent Panama strain, also activate
ZDHHC22 expression, but to a lesser extent (Figure 2).
NS1 has recently been described to induce the transcription of
hundreds of cellular genes by “read through” transcription of polymer-
ase II past the end of genes by global inhibition of transcription termi-
nation. The NS1 activity is a consequence of inhibiting the poly(A)
sensing (PAS) subunit of the cleavage and polyadenylation specificity
factor, CPSF30, since an Influenza virus H5N1 strain lacking the 73 C-
terminal amino acids (including the CPSF30 binding site) does not
induce readthrough transcription (Heinz et al., 2018). We therefore
compared the CPSF30 binding site of FPV NS1 with the
corresponding amino acids in the NS1 proteins which exhibit a weaker
effect on upregulation of ZDHHC22. Figure 7a shows part of a crystal
structure of a complex formed between zinc finger domains of
CPSF30 and the C-terminal domain of NS1 from the human Udorn
virus, which contains identical amino acids at the binding site as NS1
from FPV. Its core region comprises a highly conserved hydrophobic
binding pocket in NS1 (labelled as cyan sticks), but two other con-
served amino acids in NS1 (Phe103 and Met106) stabilise binding to
CFSP30 (Das et al., 2008). These two residues are exchanged to Ser
and Ile, respectively in NS1 of PR8, and as a consequence it does not
bind to CFSP30 in vitro. Two other residues are substituted in NS1 of
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WSN: Asp189 is exchanged to Asn and Asp101 to His. The latter resi-
due, which is close to the binding site, is exchanged to Asn in the Pan-
ama strain. Interestingly, two other residues at positions 114 and
125, which have been shown to affect binding to CFSP30 (Clark,
Nogales, Martinez-Sobrido, Topham, & DeDiego, 2017; Rodriguez,
Nogales, Iqbal, Perez, & Martinez-Sobrido, 2018), are exchanged in all
three strains. Gly125 is exchanged by an acidic residue and Ser114 by
a proline. Although residue 114 is quite remote from the binding site,
Pro is known to cause a kink in the secondary structure of proteins
which might indirectly affect the interaction with CFSP30. Thus,
amino acid substitutions in the CFSP30 binding site might be partially
responsible for the different activities of the NS1 proteins we tested.
However, since NS1 from PR8 virus does not bind to CFSP30 but
nevertheless activates expression of ZDHHC22 there might be other
mechanisms involved.
NS1 is a multifunctional protein and interacts with several cellular
proteins for which binding sites have been identified (Klemm
et al., 2017; Krug, 2015; Marc, 2014). To get an idea which amino acids
and hence binding partners might be responsible for the presumably
stronger effect of the avian NS1, we aligned the NS1 sequences of the
four investigated Influenza A viruses. We found 15 amino acids that
are present in NS1 of FPV, but not in NS1 of any of the other strains
investigated here; 12 of them are highlighted in the crystal structure of
the molecule (Figure 7b), either as purple sticks (indicating conservative
amino acid exchanges) or as red sticks (non-conservative exchanges).
Five exchanges are located in the N-terminal RNA-binding domain, one
affects a known SUMOylation site: position 70 is a Glu in NS1 of FPV,
but a Lys in the human NS1 proteins, with only the latter being a poten-
tial SUMOylation acceptor site (Santos et al., 2013). Two amino acids
are located in the between-strains variable linker region, which might
affect the positioning of the RBD relative to the downstream effector
domain. The remaining five amino acids are located in the effector
domain; three are conservative exchanges that are unlikely to have a
strong effect on the functionalities of NS1.
Three other exchanges are located in the intrinsically disordered
C-terminus of NS1 (Hale, 2014), which is not present in the crystal
structure: Ile230 is exchanged to Leu, Glu227 is exchanged to Arg and
Pro215 is exchanged to Thr (Figure 7c). The latter is a known threo-
nine phosphorylation site in the human NS1 proteins (Hutchinson
et al., 2012). Interestingly, in FPV and other avian viruses Pro215 is
F IGURE 7 Structure of NS1 indicating amino acids present only in NS1 from FPV. (a) Detail of the structure of NS1 bound to the F2F3
fragment of human CPSF30. This crystal structure reveals an NS1:F2F3 tetrameric complex with two F2F3 binding pockets, but only one is
depicted here. NS1 is shown as green and the F2F3 fragment as blue cartoons. The main hydrophobic pocket in NS1 for binding to CPSF30 is
shown in cyan. Residues which are different between FPV NS1 and at least one of the other NS1 proteins are shown as red sticks. The figure was
created with Pymol from PDB file 2RHK containing an NS1 protein from the influenza strain Udorn/307/1972, H3N2 (Das et al., 2008).
(b) Structure of NS1 showing the amino acid differences between NS1 from FPV and from other NS1 proteins. The structure of a NS1 monomer
is shown as a cartoon. The RNA-binding domain (RBD) is connected by a linker to the effector domain (ED). Residues which are present only in
NS1 from FPV are shown as sticks, either coloured purple if they are exchanged by a similar amino acid or coloured red if they are exchanged by
a non-similar amino acid in the other NS1 proteins analysed here. The main site in NS1 for binding to CFSP30 is coloured in blue. Two amino
acids which modulate binding to CFSP30 (Phe 103, Met106) are shown as blue sticks. The figure was created with Pymol from PDB file 4OPH
containing an NS1 protein from an avian H6N6 virus (Carrillo et al., 2014). (c) Amino acid sequence alignment at the C-terminus of NS1 proteins.
Amino acids in NS1 of FPV not present in any of the other NS1s are highlighted in purple (conservative exchanges) and red (non-conservative
exchanges), respectively. Pro is part of the Src-homology binding motif PXϕPX+ (Pro, any amino acid, hydrophobic, Pro, any amino acid, acidic),
that is required for binding to the cellular Abl-kinase, which is not present in the other NS1 proteins
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part of a second Src-homology binding motif, which is required for
binding to and inhibition of the cellular kinase c-Abl that controls mul-
tiple signalling processes (Hrincius et al., 2014). Thus, inhibition of the
cellular c-Abl kinase might be part of the mechanism responsible for
the higher activity of NS1 from FPV.
In summary, it is reasonable to assume that NS1 activates over-
expression of ZDHHC22 by two mechanisms: a basic, weakly effec-
tive mechanism that can be executed by many NS1 proteins and a
more efficient mechanism in NS1 from FPV. The latter might involve
inhibition of the cellular c-Abl kinase and/or binding to CFSP30. How-
ever, the physiological role of the upregulation of ZDHHC22 remains
unclear, as infectious titers of two Influenza A viruses were not
reduced in ΔZDHHC22 A549 epithelial cells. Since one main function
of NS1 is the inhibition of the innate immune response, including the
induction of the type I interferon production, the precise role of
ZDHHC22 overexpression might become more evident under condi-
tions that take into account the communication networks of an inte-
grated immune response.
4 | EXPERIMENTAL PROCEDURES
4.1 | Cell culture and virus infection
Human lung epithelium cells A549, Calu-3 and MDCK-II cells were
grown in Dulbecco's modified Eagle's medium (DMEM, PAN-Biotech)
supplemented with 10% heat-inactivated fetal bovine serum at 37C
with 5% CO2. Human influenza A/WSN/33 (H1N1) as well as a
mutant of the highly pathogenic strain fowl plaque virus (FPV M1,
A/chicken/Rostock/8/1934, H7N1) was used in the experiments, that
contains the sequence PSKGR instead of PSKKRKKR at the C-
terminus of HA1 (Wagner et al., 2013). This mutation creates a low
pathogenic strain suitable for working in a BSL2 laboratory. Virus
strains were propagated and titrated on MDCK-II cell line. ΔNS1
mutant influenza viruses (PR8 and Panama strains) are described in
(Matthaei, Budt, & Wolff, 2013) and (Ludwig et al., 2002).
Cells were infected at multiplicity of infection (MOI) of 1. After
1 hr incubation with the virus, the inoculation media was replaced with
pre-warmed infection media supplemented with 0.1% BSA and 1 μg/ml
TPCK-trypsin and incubated at 37C for 5 hr. To assess viral growth
kinetics WT as well as ΔZDHHC22 A549 cells were inoculated with
influenza viruses at a multiplicity of infection (MOI) of 0.01 plaque for-
ming units (PFU). One hour post-infection, inoculum was removed and
cells were washed with PBS and maintained in freshly prepared infec-
tion media (DMEM+0.1%BSA and 0.25 μg TPCK Trypsin) for virus rep-
lication. Viral supernatants were harvested at indicated time points and
titers were determined by plaque assay in MDCK-II cells.
4.2 | Plasmids and antibodies
Viral cDNAs encoding the NS1 reading frames of the indicated IAV
strains were integrated into the pCAGGS vector as described
(Unterstab et al., 2005). The primary antibodies used in this study
were rabbit anti-Hemagglutinin antibody (WSN strain) (1:3,000 dilu-
tion in 5% non-fat milk; Genetex, GTX127357), homemade rabbit
anti-Hemagglutinin antibody (FPV strain) and homemade antibody
against HA2 of FPV (1:3,000 dilution in 5% non-fat milk). Monoclonal
mouse anti-influenza A NS1 (1:1,000 dilution in 5% non-fat milk, SC-
130568, which was raised against recombinant NS1 protein of Influ-
enza A/Puerto Rico/8/34. (H1N1) virus, with epitope mapping to the
N-terminal domain). Mouse anti-Plakophilin-2 antibody, clone 8H6
(1:1,000 dilution in 5% non-fat milk, MABT394). Rabbit Anti-β-Actin
(13E5) (1:1,000 dilution in 5% non-fat milk, #4970 Cell signalling).
Mouse monoclonal anti-M2 antibody (1:2,000 dilution in 5% non-fat
milk; abcam, ab5416) and mouse monoclonal anti-Flotillin-2 antibody
(1:1,000 dilution in 5% non-fat milk; 610383, BD Biosciences). The
secondary HRP antibodies (anti-rabbit, 1:5,000, abcam, ab191866 and
anti-mouse, 1:2,000, Biorad, 1706516) both diluted in in 5% non-
fat milk).
4.3 | RNA isolation and cDNA synthesis
Supernatants from virus-infected cells were removed, cells were
scraped from the plate and pelleted by centrifugation. Total RNA from
lysed cell pellets was extracted using the RNeasy® plus Mini Kit
(Qiagen, Germany) according to the manufacturer's instructions.
cDNA synthesis was carried out immediately after RNA purification
using High Capacity cDNA Reverse Transcription kit (Applied Bio-
systems, USA). A 20 μl reaction contains 10 μl of ×2 RT mastermix
and 10 μl RNA template (1.2 μg) under the following cycling condi-
tions: 25C for 10 min, 37C for 120 min followed by 85C for 5 min.
RNA and cDNA concentrations were measured with Nanodrop, the
latter was stored at −80C until use.
4.4 | Quantitative PCR
Quantitative PCR was used to analyse changes in mRNA levels of
ZDHHCs in uninfected and virus-infected or in untransfected versus
transfected cells. PCR primer pairs (listed in Table S3) for each
ZDHHC were selected to generate amplicons of 80–225 base pairs.
All primer sets were designed to work at the same annealing tempera-
tures to allow detection of all ZDHHCs within the same qPCR run. All
primers were synthesised by Integrated DNA Technologies (IDT-DNA,
BVBA, Belgium). A 10 μl PCR reaction consists of 5 μl 2xpowerUp
SYBR green master mix (Applied Biosystems, USA), 400 nM of each
primer and 100 ng cDNA template in a qPCR 96-well plate
(Eurogentec, Belgium). Non-template controls were also included as
an indicator for contamination. The cycling conditions were as fol-
lows: UDG (uracil-DNA glycosylase) activation step at 50C for 2 min,
followed by incubation at 95C for 2 min to activate the Dual-lock™
DNA polymerase. Amplification was then performed on an Applied
Biosystems 7,500 Fast Real-Time PCR machine using 40 cycles of
denaturation at 95C for 15 s and annealing and extension at 60C
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for 30 s. Following amplification, amplicon specificity and purity for
each ZDHHC was confirmed by melting curve analysis. Relative
expression values for each ZDHHC mRNA were normalised to human
GAPDH, that is, the Ct-value obtained for GAPDH was subtracted
from the Ct-value obtained for a ZDHHC (= ΔCt). The relative
changes in ZDHHC expression levels were calculated by subtracting
the ΔCt of uninfected or untransfected cells from infected or trans-
fected cells and then using the following formula Fold Change =
2−ΔΔCt = 2−(ΔCt of influenza infected – ΔCt of Mock infected). (Livak &
Schmittgen, 2001).
4.5 | Generation of ZDHHC22 knockout cells with
CRISPR/Cas9
Guide RNA (gRNA)-gene specific oligo sequences were selected to
minimise the likelihood of off-target cleavage using the online MIT
CRISPR and Atum gRNA designer tools (https://www.atum.bio/
eCommerce/cas9/input). The sequence “ACCG” was added to the 50
end of the gRNA-specifying oligonucleotide sequence and “AAAC”
was added to the 50 end of the reverse complement of the sgRNA-
specifying oligonucleotide to allow cloning using the BsmBI restriction
enzyme. The two oligonucleotides were then phosphorylated using
the following conditions: gRNA forward oligo (10 μM); gRNA reverse
complement oligo (10 μM); ×10 T4 ligation buffer and T4 polynucleo-
tide kinase (5 units) (New England Biolabs) in a total volume of 20 μl
for 1 hr at 37C followed by inactivation at 65C for 20 min. The
phosphorylated oligonucleotides (10 μl each) were then annealed in
30 μl duplex buffer (60 mM HEPES pH 7.4 + 200 mM sodium acetate)
at 95C for 5 min; and then cooled down to 30C at (0.01C/sec) in a
gradient PCR thermomixer.
The phosphorylated annealed oligonucleotides were cloned into
pRP-418, a plasmid that expresses Flag-tagged Cas9, using Golden
Gate cloning with the following conditions: 1 μg of circular pRP-418
vector is first digested by BsmBI restriction enzyme in NEB buffer 3.1
(×10) (New England Biolabs) at 55C for 2 hr followed by enzyme
inactivation at 80C/20 min, Agarose gel electrophoresis and purifica-
tion. Ligation of annealed oligonucleotides with linearized vector was
carried out using T4 ligase under the following conditions: 100 ng
BsmBI linearized pRP-418 vector, 1:10 Annealed oligos, T4 ligase; and
T4 DNA ligase buffer (10x). 16C/overnight. Ligation reaction was
then transformed into Top10 competent cells. Colonies were picked
and analysed for successful cloning using sequencing by U6 promoter
specific sequencing primer (50TTTGCTGTACTTTCTATAGTG03).
To determine the lowest concentration of puromycin that kills
100% of non-transfected cells confluent cells were incubated with
increasing concentrations of puromycin (0–5 μg/ml) for 5–7 days. For
transfection cells were seeded in six well plates such that they reach
60–70% confluency the next day. Cells were transfected with the
pRP-418 plasmid expressing single gRNA for the target gene as well
as Cas9 nuclease using Lipofectamine 3,000 following manufacturer
instructions (Thermo Scientific). Transfected cells were incubated in
complete growth media for 48 hr followed by addition of puromycin
selection media (2 μg/ml) and left until death of all non-transfected
cells. After puromycin selection, the remaining single-cell clones were
isolated by limiting dilution in 96 well plate / or by cell culture cloning
cylinders. Single cell clones have been expanded and screened by PCR
on genomic DNA using primers flanking Cas9 edit site.
4.6 | Palmitoylation assays
4.6.1 | Acyl-Resin assisted capture (Acyl-RAC)
Protein S-acylation was analysed by the Acyl-RAC assay as described
(Werno & Chamberlain, 2015), with some modifications. Cells in a six
well plate were washed with PBS 16 hr after infection, lysed in 500 μl
buffer A (0.5% Triton-X100, 25 mM HEPES [pH 7.4], 25 mM NaCl,
1 mM EDTA, and protease inhibitor cocktail). Disulfide bonds were
reduced by adding Tris (2-carboxyethyl) phosphin (TCEP, Carl Roth,
HN95.2) to a final concentration of 10 mM and incubated at RT for
30 min. Free SH-groups were blocked by adding methyl
methanethiosulfonate (MMTS, Sigma, 208,795, dissolved in 100 mM
HEPES, 1 mM EDTA, 87.5 mM SDS) to a final concentration of 1.5%
(v/v) and incubated for 4 hr at 40C. Subsequently, 3 volumes of ice-
cold 100% acetone was added to the cell lysate and incubated at
−20C overnight. Precipitated proteins were pelleted at 5,000 × g for
10 min at 4C. Pelleted proteins were washed five times with 70%
(v/v) acetone, air-dried, and then re-suspended in binding buffer
(100 mM HEPES, 1 mM EDTA, 35 mM SDS). Twenty to thirty micro-
litre of the sample was removed to check for total protein expression
by Western-blotting. The remaining lysate was divided into two equal
aliquots. One aliquot was treated with hydroxylamine (0.5 M final
concentration, added from a 2 M hydroxylamine stock adjusted to
pH 7.4) to cleave thioester bonds. The second aliquot was treated
with 0.5 M Tris–HCl pH 7.4. Thirty microlitre thiopropyl Sepharose
beads (Sigma, T8387), which were beforehand activated by incubation
for 15 min in aqua dest, were added at the same time to capture free
SH-groups. Samples were incubated with beads overnight at room
temperature on a rotating wheel. The beads were then washed 5x in
binding buffer and bound proteins were eluted from the beads with
×2 non-reducing SDS-PAGE sample buffer for 5 min at 95C. Samples
were then subjected to SDS-PAGE and Western-blotting.
4.6.2 | Metabolic labeling with fatty acid analogue,
immunoprecipitation and click chemistry
Wild type and ΔZDHHC22 A549 cells were infected at an MOI of
1 for 5 hr, then washed ×3 with serum free DMEM and incubated
with the 17-ODYA fatty acid analogue (1:1,000) (Cayman chemicals)
in DMEM supplemented with 5% dialyzed serum for 6 hr. For immu-
noprecipitation, cells were rinsed three times with cold PBS and lysed
for 30 min at 4C in IP-buffer (0.5% NP-40, 500 mM Tris pH 7.4,
20 mM EDTA, 10 mM NaF, 2 mM benzamidine and protease inhibitor
cocktail). Cell lysates were centrifuged (5,000 × g for 5 min) and
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supernatants were incubated with 20 μl of sepharose protein G beads
(GE Healthcare) for 1 hr at 4C. Cleared supernatants were incubated
with viral antibodies (FPV-HA2) or WSN-HA and 20 μl protein G
beads overnight at 4C on a rotating wheel. Bound proteins were
washed ×3 with IP-buffer and click chemistry reaction was done for
1 hr at room temperature (RT) using (1.25 Mm TAMRA Azide, 50 mM
TCEP, 1x TBTA and 50 mM CuSo4) (Martin, 2013). Click reaction was
stopped by adding 4x sample loading buffer and boiled at 95C 5 min.
Proteins were subjected to SDS-PAGE and the fluorescence in the
resulting gel was visualised with a Typhoon 9400 fluorescence
scanner.
4.6.3 | SDS-PAGE and western-blot
After sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) using 12% polyacrylamide, gels were electrophoretically
transferred (200 mA for 1 hr) onto polyvinylidene difluoride (PVDF)
membranes (GE Healthcare). After blocking (blocking solution: 5%
skim milk powder in PBS with 0.1% Tween-20 [PBST]) for 1 hr at
room temperature, membranes were incubated with the primary anti-
body overnight at 4C. The following commercial antibodies were
used: Influenza A virus H1N1 HA antibody from rabbit (Genetex,
GTX127357, 1:3,000 dilution in 5% non-fat milk), Caveolin-1 (N-20)
antibody from rabbit (Santa Cruz-894, 1:1,000) and anti-Influenza A
Virus M2 protein monoclonal antibody 14C2 from mice (abcam,
ab5416, 1:2,000). To detect H7 subtype HA we used our antiserum
against the HA2 subunit of the FPV strain at a dilution of 1:3,000.
4.6.4 | MALDI-TOF MS analysis of HA in virus
particles
Virus preparations were incubated with Iodoacetamide (30 mM final
concentration, 1 hr in dark) before SDS-PAGE separation. Protein
bands were electro-blotted onto PVDF membranes (Merck) and vis-
ualised by Ponceau S (Fluka) staining. The band corresponding to HA
was cut from the membrane and subjected to trypsin in-gel hydrolysis
as described in (Kordyukova, Krabben, Serebryakova, & Veit, 2019).
Briefly, small membrane pieces were rinsed with 100–200 μl of 40%
acetonitrile/50 mM NH4HCO3 (pH 7.5) and digested with 5–10 μl of
trypsin (Promega, 15 ng/μl in 80% acetonitrile/50 mM NH4HCO3,
pH 7.5) for 1–2 hr at 37C. The reaction was stopped by adding a
twofold volume of 0.5% trifluoroacetic acid. An aliquot (1–2 μl) of the
water-acetonitrile solution containing hydrophilic and slightly hydro-
phobic peptides was used to confirm the protein identity by MALDI-
TOF MS analysis and Mascot server (www.matrixscience.com) search.
Strongly hydrophobic peptides were further extracted from the mem-
brane pieces with a mixture (1:1, 10–20 μl) of hexafluoroisopropanol
(HFIP) and chloroform for 2 hr to overnight. The water-acetonitrile
and HFIP/chloroform extracts were combined, several μl of 0.5%
trifluoroacetic acid was added to the solution until phase separation
occurred, and the organic phase was collected for MALDI-TOF MS
analysis. Sample aliquots (1 μl) were mixed on a steel target with an
equal volume of 2,5-dihydroxybenzoic acid saturated solution in 30%
acetonitrile/0.5% trifluoroacetic acid solution. Mass spectra were
recorded on an UltrafleXtreme MALDI-TOF/TOF mass spectrometer
(Bruker Daltonics, DE) equipped with an Nd laser. The MH+ molecular
ions were detected in linear mode; the accuracy of mass peak measur-
ing was within 0.01%. Matching of the peaks to the HA protein
sequence was manually interpreted using GPMAW software
(Lighthouse data, Denmark). The amount of stearate was calculated
from the MS peak intensities using the method developed earlier
(Serebryakova, Kordyukova, Baratova, & Markushin, 2006).
4.6.5 | Quantitative mass spectrometry and data
analysis
Wild type and ΔZDHHC22 eluates of hydroxylamine treated
(+NH2OH) and untreated (−NH2OH) acyl-RAC-enriched fractions
were run on an SDS-PAGE gel and stained with Coomassie. Gel lanes
were cut into 24 parallel bands of equal size. Bands from untreated
samples were labelled with 16O (light) and +HA bands with 18O
(heavy) via in-gel tryptic digestion, as previously described (Morrison
et al., 2015). After deactivation of trypsin by acidification to pH  2.0
and heating to 95C for 20 min, light and heavy peptide samples of
corresponding bands were mixed, dried on a speed vac, and
resuspended in 15 μl 0.1% (v/v) TFA and 5% (v/v) acetonitrile. 6.5 μl
of this peptide mixture was injected onto a reversed-phase capillary
nano liquid chromatography (LC) system (Ultimate 3,000, Thermo Sci-
entific, USA) connected in-line to an Orbitrap Velos mass spectrome-
ter (Thermo Scientific). Separation by LC was performed on a capillary
column (Acclaim PepMap100 C18, 2 μm, 100 Å, 75 μm i.d. × 25 cm)
at an eluent flow rate of 200 nl/min. The mobile phase A was com-
posed of 0.1% formic acid in water, while the mobile phase B was
0.1% formic acid in acetonitrile. After pre-equilibration of the column
with 3% mobile phase B, mobile phase B was linearly increased from
3% to 50% over 50 min. Mass spectra were measured in a data-
dependent mode with a single MS survey scan, a m/z range of
350–1,500, an Orbitrap resolution of 60,000, and MS/MS scans of
the 20 precursor ions with the highest intensities in the linear trap
quadrupole. Two biological replicates were performed for each cell
line. Raw files of each condition were searched together using Mascot
Distiller (version 2.7.1.0) software against a custom database con-
taining reviewed human proteins combined with influenza A virus
(strain A/Wilson-Smith/1933-H1N1) proteins from Uniprot (accessed
August 2017). The mass tolerance and sequence ion tolerance were
set to 10 ppm and 0.35 Da, respectively. For quantification, only
unique peptides identified better than homology were included, and
proteins with fewer than two peptide heavy/light (H/L) ratios were fil-
tered out. Filtered datasets of quantified protein ratios from all four
replicates were then normalised by dividing all ratios by the median
H/L ratio of each dataset and then combined.
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